Identify Patients at Risk of Moderate or Severe OSA During ENT Examination
1 other identifier
observational
110
1 country
1
Brief Summary
The management of OSA is multidisciplinary. Today, there are many self-evaluation questionnaires aiming at predicting or evaluating the severity of OSA. However, no clinical score takes into account the specificities of the ENT clinical examination, which is a major actor in the management of the disease. The aim of this study is to create a clinical score predictive of the diagnosis and severity of OSA, using already published data, completed with the specificities of the ENT clinical examination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 25, 2023
CompletedFirst Posted
Study publicly available on registry
April 12, 2023
CompletedApril 12, 2023
April 1, 2023
1.3 years
March 25, 2023
April 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
clinical sign and apnea/hypopnea index
Measurement of the association between clinical signs assessed during the ENT examination and the sleep apnea hypopnea index
Statistical analyses are performed at the end of the recruitment period, when each patient has undergone a clinical examination and a ventilatory polygraph. Measurement date: October 2022.
Study Arms (1)
OSA screening
To
Interventions
The detailed management is not different from that usually practiced in our department. Each patient benefits from an ENT consultation where an interrogation is carried out concerning the sleep disorders, the answer to the usual questionnaires screening for sleep disorders, a detailed ENT clinical examination including a nasofibroscopy. Each patient then benefits from a sleep recording by ventilatory polygraph.
Eligibility Criteria
The patients included correspond to the patients referred to the ENT consultation at the Nancy University Hospital for clinical screening of sleep apnea/hypopnea syndrome.
You may qualify if:
- \- Adult subjects (\> 18 years old), referred to the ENT consultation of the Nancy University Hospital for ENT assessment in the context of OSA or suspicion of OSA, or consultation for the reason "snoring", or presenting clinical signs making OSA suspect.
- Patients suspected of having another sleep disorder (indication for polysomnography)
- Patients with history of upper airway surgery or an ENT tumor
You may not qualify if:
- \- Patients with poor quality video recording of nasofibroscopy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
LENAY Nicolas
Nancy, 54000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
NGUYEN Duc Trung, PhD, M.P.H
Central Hospital, Nancy, France
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr NGUYEN Duc Trung - Hospital practitioner
Study Record Dates
First Submitted
March 25, 2023
First Posted
April 12, 2023
Study Start
May 1, 2021
Primary Completion
September 1, 2022
Study Completion
October 1, 2022
Last Updated
April 12, 2023
Record last verified: 2023-04